Overview
Announcements

Ordinary Index Rebalancing in the Solactive Pharma & Biotech Opportunity Index | February 2021

In the ordinary rebalance the following composition will be implemented effective open 18.02.2021:

3SBIO INC
AMARIN CORPORATION PLC -ADR
APHRIA INC
ASCENDIS PHARMA A/S
AURINIA PHARMACEUTICALS INC
AURORA CANNABIS INC
BLUEBIRD BIO INC
CHINA TRADITIONAL CHINESE MEDICINE HOLDINGS CO LTD
CORCEPT THERAPEUTICS INC
CRONOS GROUP INC
CSPC PHARMACEUTICAL GROUP LTD
EMERGENT BIOSOLUTIONS INC
EXELIXIS INC
GALAPAGOS NV
GENEXINE CO LTD
ICON PLC
IONIS PHARMACEUTICALS INC
IPSEN SA
LIGAND PHARMACEUTICALS INC
LUYE PHARMA GROUP LTD
MEDPACE HOLDINGS INC
NEKTAR THERAPEUTICS
PRA HEALTH SCIENCES INC
RECIPHARM AB
REGENXBIO INC
SANGAMO THERAPEUTICS INC
SINO BIOPHARMACEUTICAL LTD ORD
SWEDISH ORPHAN BIOVITRUM AB
SYNEOS HEALTH INC
XENCOR INC